Acute Lower gastroIntestinal BleedIng (ALIBI Study) in Italy — ALIBI  

Lower GI Bleeding Clinical Trial

Official title: Acute Lower gastroIntestinal BleedIng (ALIBI Study): a Multicentre Prospective, Cohort Study

Status Completed

Clinical Trial Summary

Unlike upper GI bleeding, for LGIB there is still a paucity of data on clinical presentation, patient characteristics, pathways of care and outcomes for LGIB patients. In-hospital mortality ranges from 1.2% to 8.8% (2-4), according to retrospective studies, but data from prospective series are still limited (5).

Present multicentre, prospective, observational study was designed to explore these areas, to assess variations in practice management and to identify factors associated with patient outcomes.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Gastrointestinal Hemorrhage
• Hemorrhage
• Lower GI Bleeding

• NCT number: NCT04364412
• Study type: Observational [Patient Registry]
• Source: Valduce Hospital
• Status: Completed
• Start date: April 1, 2019
• Completion date: May 18, 2020